 89bio, Inc NASDAQ: ETNB was plunging almost 10 lower on Friday in sympathy with the general market, which saw the SP 500 plummeting over 2. In May, a number of analysts weighed in on 89bio following the biopharmaceutical company printing its first-quarter earnings on May 11. 